| Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ... Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012 | 406 | 2012 |
| Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ... Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014 | 325 | 2014 |
| Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma J Gunawardana, FC Chan, A Telenius, B Woolcock, R Kridel, KL Tan, ... Nature genetics 46 (4), 329-335, 2014 | 238 | 2014 |
| Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling P Massari, A Visintin, J Gunawardana, KA Halmen, CA King, ... The Journal of Immunology 176 (4), 2373-2380, 2006 | 204 | 2006 |
| Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ... Journal of Clinical Oncology 37 (34), 3300, 2019 | 112 | 2019 |
| Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions C Lees, C Keane, MK Gandhi, J Gunawardana British journal of haematology 185 (1), 25-41, 2019 | 87 | 2019 |
| EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ... Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021 | 73 | 2021 |
| Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma D Bararia, JA Hildebrand, S Stolz, S Haebe, S Alig, CP Trevisani, ... Cell reports 31 (5), 2020 | 62 | 2020 |
| EBV microRNA-BHRF1-2-5p targets the 3′ UTR of immune checkpoint ligands PD-L1 and PD-L2 AS Cristino, J Nourse, RA West, MB Sabdia, SC Law, J Gunawardana, ... Blood, The Journal of the American Society of Hematology 134 (25), 2261-2270, 2019 | 53 | 2019 |
| The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma C Keane, J Tobin, J Gunawardana, S Francis, G Gifford, S Gabrielli, A Gill, ... European journal of haematology 103 (3), 200-207, 2019 | 52 | 2019 |
| Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation E Viganò, J Gunawardana, A Mottok, T Van Tol, K Mak, FC Chan, ... Blood, The Journal of the American Society of Hematology 131 (18), 2036-2046, 2018 | 46 | 2018 |
| Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor‐1 in childhood obesity: evidence of a procoagulant state A Singh, GD Foster, J Gunawardana, TA McCoy, T Nguyen, ... British journal of haematology 158 (4), 523-527, 2012 | 44 | 2012 |
| Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia A Singh, G Boden, C Homko, J Gunawardana, AK Rao Diabetes care 35 (6), 1322-1327, 2012 | 40 | 2012 |
| Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2-and NF-κB-independent manner P Massari, J Gunawardana, X Liu, LM Wetzler Infection and immunity 78 (3), 994-1003, 2010 | 35 | 2010 |
| Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third … SC Law, T Hoang, K O’Rourke, JWD Tobin, J Gunawardana, D Loo-Oey, ... American Journal of Transplantation 21 (10), 3465-3471, 2021 | 15 | 2021 |
| Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma K Nath, SC Law, MB Sabdia, J Gunawardana, LM de Long, D Sester, ... Blood Advances 5 (12), 2644-2649, 2021 | 11 | 2021 |
| The tumor microenvironment of nodular lymphocyte predominant Hodgkin lymphoma is a unique immunobiological entity distinct from classical Hodgkin lymphoma J Gunawardana, K Bednarska, SC Law, J Lee, MB Sabdia, JWD Tobin, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 5 | 2018 |
| Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade K Nath, SC Law, MB Sabdia, LM De Long, M Shanavas, JWD Tobin, ... Blood 134, 2793, 2019 | 4 | 2019 |
| The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphoma JWD Tobin, C Keane, P Mollee, S Birch, C Gould, J Gunawardana, ... Blood 130, 728, 2017 | 3 | 2017 |
| Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma H Tsang, AM Patch, C Keane, SC Law, J Gunawardana, P Blombery, ... Blood 136, 37-38, 2020 | 2 | 2020 |
Christian SteidlProfessor, Department of Pathology and Laboratory Medicine, University of British ColumbiaVerified email at bccancer.bc.ca
